Biocytogen will be attending the 10th CAR-TCR Summit from September 23rd-26th in Boston, MA! Join us to learn more about topics such as solid tumor targeting and the development landscape in cell therapies with professional keynote speakers, in addition to great opportunities to collaborate with colleagues in and out of the area. Visit us at Booth #27 to explore our cutting-edge research in human antibodies and learn more about our team's mission in advancing life sciences. The summit offers a unique opportunity to showcase scientific breakthroughs and engage in meaningful discussions about shaping a disease-free future.
What is the 10th CAR-TCR Summit?
CAR-TCR celebrates the decade of dedicated research, discovery and development towards tackling the innovation of Cell Therapy. The 900+ participants that attend come together and attend poster sessions, 1 on 1 meetings, dedicated networking times, and relaxing drinks receptions. Learn more about coverage about multiple cell types, participate in the new Biotech and Pharma partnering day and gain Insight across multiple scopes in life sciences that hope to make it in clinics and beyond.
Event Overview
Date: Sep. 23rd - 26th, 2025
Venue: Boston Marriott Copley Place, 110 Huntington Ave, Boston, MA
Event Schedule
For a more in-depth overview of the agenda, please refer to CAR-TCR Agenda
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you in Boston, MA!
